Jeah (Kyoungrae) Jung, PhD
Associate Professor, Health Policy and Administration
Associate Professor, Department of Public Health Sciences
Associate Professor, Department of Public Health Sciences
Scientific Program:Cancer Control
- Pharmaceutical Preparations
- Medicare Part D
- Costs and Cost Analysis
- Delivery of Health Care
- Drug Therapy
- Patient Protection and Affordable Care Act
- Home Care Agencies
- Home Care Services
Jung, J, Du, P, Feldman, R & Riley, T 2020, 'Discontinuation of new hepatitis C drugs among Medicare patients', American Journal of Managed Care, vol. 26, no. 2, pp. 84-88.
Kalidindi, Y, Jung, J, Segel, J & Leslie, D 2020, 'Impact of Length of Hospice on Spending and Utilization Among Medicare Beneficiaries With Lung Cancer', American Journal of Hospice and Palliative Medicine. https://doi.org/10.1177/1049909120909304
Shooshtari, A, Kalidindi, Y & Jung, J 2019, 'Cancer care spending and use by site of provider-administered chemotherapy in Medicare', American Journal of Managed Care, vol. 25, no. 6, pp. 296-300.
Segel, JE & Jung, J 2019, 'Coverage, financial burden, and the patient protection and affordable care act for patients with cancer', Journal of oncology practice, vol. 15, no. 12, pp. e1035-e1049. https://doi.org/10.1200/JOP.19.00138
Xu, WY, Shooshtari, A & Jung, JK 2019, 'Disparities in cost-related drug nonadherence under the Affordable Care Act', Journal of Pharmaceutical Health Services Research, vol. 10, no. 2, pp. 177-185. https://doi.org/10.1111/jphs.12295
Xu, WY, Wickizer, TM & Jung, JK 2019, 'Effectiveness of Medicare cost-sharing elimination for Cancer screening on utilization', BMC health services research, vol. 19, no. 1, 392. https://doi.org/10.1186/s12913-019-4135-9
Wu, B, Jung, J, Kim, H & Polsky, D 2019, 'Entry regulation and the effect of public reporting: Evidence from Home Health Compare', Health Economics (United Kingdom), vol. 28, no. 4, pp. 492-516. https://doi.org/10.1002/hec.3859
Kalidindi, Y, Segel, J & Jung, J 2020, 'Impact of Hospice on Spending and Utilization Among Patients With Lung Cancer in Medicare', American Journal of Hospice and Palliative Medicine, vol. 37, no. 4, pp. 286-293. https://doi.org/10.1177/1049909119878446
Jung, J, Du, P, Feldman, R, Kong, L & Riley, T 2019, 'Racial/ethnic and socioeconomic disparities in use of direct-acting antivirals among Medicare beneficiaries with chronic hepatitis C, 2014-2016', Journal of Managed Care and Specialty Pharmacy, vol. 25, no. 11, pp. 1236-1242. https://doi.org/10.18553/jmcp.2019.25.11.1236
Jung, J, Feldman, R & Kalidindi, Y 2019, 'The impact of integration on outpatient chemotherapy use and spending in Medicare', Health Economics (United Kingdom), vol. 28, no. 4, pp. 517-528. https://doi.org/10.1002/hec.3860
Kalidindi, Y, Jung, J & Feldman, R 2018, 'Differences in spending on provider-administered chemotherapy by site of care in Medicare', The American journal of managed care, vol. 24, no. 7, pp. 328-333.
Jung, J & Feldman, R 2018, 'Growing Reinsurance Payments Weaken Competitive Bidding in Medicare Part D', Health Services Research, vol. 53, no. 6, pp. 4371-4380. https://doi.org/10.1111/1475-6773.12866
Jung, J, Xu, WY & Kalidindi, Y 2018, 'Impact of the 340B Drug Pricing Program on Cancer Care Site and Spending in Medicare', Health Services Research, vol. 53, no. 5, pp. 3528-3548. https://doi.org/10.1111/1475-6773.12823
Lim, D & Jung, J 2019, 'Racial-Ethnic Variations in Potentially Inappropriate Psychotropic Medication Use Among the Elderly', Journal of Racial and Ethnic Health Disparities, vol. 6, no. 2, pp. 436-445. https://doi.org/10.1007/s40615-018-00541-0
Kulaylat, AS, Jung, J, Hollenbeak, CS & Messaris, E 2018, 'Readmissions, penalties, and the Hospital Readmissions Reduction Program', Seminars in Colon and Rectal Surgery, vol. 29, no. 2, pp. 55-59. https://doi.org/10.1053/j.scrs.2018.01.003
Kalidindi, Y, Jung, J & Feldman, R 2018, 'The authors respond and stand behind their findings', The American journal of managed care, vol. 24, no. 10.
Kim, H, Wu, B & Jung, J 2017, 'Competition and Gaming Behavior by Medicare Home Health Agencies in the United States', Home Health Care Management and Practice, vol. 29, no. 2, pp. 63-69. https://doi.org/10.1177/1084822316679978
Jung, J, Xu, WY & Cheong, C 2017, 'In-gap discounts in medicare Part D and specialty drug use', American Journal of Managed Care, vol. 23, no. 9, pp. 553-559.
Lim, D & Jung, JK 2017, 'Racial-ethnic differences in off-label antidepressant use, by insurance type', Psychiatric Services, vol. 68, no. 12, pp. 1271-1279. https://doi.org/10.1176/appi.ps.201600445
Jung, J, Feldman, RD & McBean, M 2017, 'The Price Elasticity of Specialty Drug Use: Evidence from Cancer Patients in Medicare Part D', Forum for Health Economics and Policy, vol. 20, no. 2, 20160007. https://doi.org/10.1515/fhep-2016-0007
Jung, JK, Feldman, R, Cheong, C, Du, P & Leslie, D 2016, 'Coverage for hepatitis C drugs in Medicare Part D', The American journal of managed care, vol. 22, no. 6, pp. SP220-SP226.
Bhandari, N, Shi, Y & Jung, K 2016, 'Patient experience of provider refusal of medicaid coverage and its implications', Journal of Health Care for the Poor and Underserved, vol. 27, no. 2, pp. 479-494. https://doi.org/10.1353/hpu.2016.0096
Jung, J & Feldman, R 2017, 'Racial-Ethnic Disparities in Uptake of New Hepatitis C Drugs in Medicare', Journal of Racial and Ethnic Health Disparities, vol. 4, no. 6, pp. 1147-1158. https://doi.org/10.1007/s40615-016-0320-2
Xu, WY & Jung, JK 2017, 'Socioeconomic Differences in Use of Low-Value Cancer Screenings and Distributional Effects in Medicare', Health Services Research, vol. 52, no. 5, pp. 1772-1793. https://doi.org/10.1111/1475-6773.12559
Jung, JK, Wu, B, Kim, H & Polsky, D 2016, 'The Effect of Publicized Quality Information on Home Health Agency Choice', Medical Care Research and Review, vol. 73, no. 6, pp. 703-723. https://doi.org/10.1177/1077558715623718